ClinicalTrials.govpublic full text
AMG 172 First in Human Study in Patients With Kidney Cancer
renal cell adenocarcinoma, clear cell renal carcinoma, clear cell renal cell carcinoma, renal cell carcinoma, amgen, phase 1, first in human, relapsed / refractory renal cell carcinoma (rcc), kidney cancer, clinical trial, antibody drug conjugate (adc), open-label
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 982182
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.